Lactate concentrations distinguish between nucleoside neuropathy and HIV neuropathy.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  AIDS (London)

• Publication date

  2003-05-02

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/00002030-200305020-00024PMID 12700465
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Severity of HIV-associated neuropathy is associated with plasma HIV-1 RNA levels

  2002cited by this paper
• Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy

  1999cited by this paper
• HIV-1 peripheral neuropathy and combination antiretroviral therapy.

  1998cited by this paper

• Peripheral Neuropathy in Virologically Suppressed People Living with HIV: Evidence from the PIVOT Trial

  2023cites this paper
• Human immunodeficiency virus–related peripheral neuropathy: A systematic review and meta‐analysis

  2020cites this paper
• HIV NEUROPATHY DRUG NAIVE PLHA

  2020cites this paper
• Peripheral neuropathy in patients with human immunodeficiency viral infection at a tertiary hospital in Ghana

  2019cites this paper
• Neuropathy of Connective Tissue Diseases and Other Systemic Diseases

  2019cites this paper
• Neuromuscular complications of HIV infection.

  2018cites this paper
• HIV/AIDS Neuropathy

  2016cites this paper
• HIV-associated peripheral neuropathies: a review

  2016cites this paper
• Toxic Neuropathies

  2015cites this paper
• 127 – Neurologic Diseases Caused by Human Immunodeficiency Virus Type 1 and Opportunistic Infections

  2015cites this paper
• Improvement of distal symmetrical polyneuropathy in patient with AIDS after switch from protease inhibitor containing antiretroviral treatment to tenofovir disoproxil fumarate, emtricitabine and rilpivirine (EVIPLERA®) therapy – Case report

  2015cites this paper
• Measurement of intraepidermal nerve fibre density in individuals with antiretroviral toxic neuropathy

  2014cites this paper
• Neurological and Psychiatric Adverse Effects of Antiretroviral Drugs

  2014cites this paper
• POLINEUROPATIA EM INDIVÍDUOS INFECTADOS PELO VÍRUS DA IMUNODEFICIÊNCIA HUMANA (HIV)

  2013cites this paper
• A Case of Possible Darunavir/Ritonavir-Induced Peripheral Neuropathy

  2013cites this paper
• Medication, Toxic, and Vitamin-Related Neuropathies

  2012cites this paper
• Influence of Age and Neurotoxic HAART Use on Frequency of HIV Sensory Neuropathy

  2012cites this paper
• Sports behaviour among HIV-infected versus non-infected individuals in a Berlin cohort

  2012cites this paper
• Neuromuscular Manifestations of HIV/AIDS

  2011cites this paper
• Peripheral neuropathy in HIV: prevalence and risk factors

  2011influential citation
• HIV Infection and the PNS

  2010cites this paper
• Chemokine Receptors and NeuroAIDS

  2010cites this paper
• Myopathies in HIV Infection

  2010cites this paper
• Distal Sensory Polyneuropathy and Other Selected Neuropathies in HIV Infection

  2009cites this paper
• Hyperalgesia induced by oral stavudine administration to rats does not depend on spinal neuronal cell death, or on spinal or systemic inflammatory cytokine secretion, or metabolic dysregulation.

  2009cites this paper
• Acetyl-L-Carnitine and NRTI-associated neuropathy in HIV-infection

  2009cites this paper
• Global Issues in Neuro-AIDS and Their Evolution over the Future of the HAART Era

  2009cites this paper
• Acetyl‐l‐carnitine and nucleoside reverse transcriptase inhibitor‐associated neuropathy in HIV infection

  2009cites this paper
• CHAPTER 30 – Neurotoxic Effects of Pharmaceutical Agents I: Anti-infectives

  2009cites this paper
• Diagnosis and management of HIV-associated neuropathy.

  2008cites this paper
• Clinical aspects of toxicity in antiretroviral therapy

  2008cites this paper
• Cytokine Genotype Suggests a Role for Inflammation in Nucleoside Analog-Associated Sensory Neuropathy (NRTI-SN) and Predicts an Individual's NRTI-SN Risk

  2008cites this paper
• international cohort Antiretroviral use and other risks for HIV-associated neuropathies in an

  2008cites this paper
• The mitochondrial pharmacogenomics of haplogroup T: MTND2*LHON4917G and antiretroviral therapy-associated peripheral neuropathy

  2008cites this paper
• A Randomized Trial Evaluating Prosaptide™ for HIV-Associated Sensory Neuropathies: Use of an Electronic Diary to Record Neuropathic Pain

  2007influential citation
• Oral glucose loading for detection of mitochondrial toxicity during HAART in HIV-infected patients.

  2007cites this paper
• istal Sensory Polyneuropathy in the Context of IV/AIDS

  2007cites this paper
• Infectious neuropathy

  2007cites this paper
• Peripheral neuropathy in HIV infection.

  2007cites this paper
• Distal sensory polyneuropathy in the context of HIV/AIDS.

  2007cites this paper
• Advances in Understanding Drug-Induced Neuropathies

  2006cites this paper
• [Clinical and subclinical neuropathy in patients with human immunodeficiency virus receiving antiretroviral therapy].

  2006cites this paper
• Antiretroviral use and other risks for HIV-associated neuropathies in an international cohort

  2006cites this paper
• Peripheral Neuropathy Associated With Nucleoside Reverse Transcriptase Inhibitor Therapy

  2006cites this paper
• Polyneuropathy and polyradiculopathy 655 27 . Neuromuscular Diseases

  2006cites this paper
• Sensory neuropathy in human immunodeficiency virus/acquired immunodeficiency syndrome patients: Protease inhibitor–mediated neurotoxicity

  2006cites this paper
• HIV neuropathy natural history cohort study

  2006cites this paper
• The influence of APOBEC3G and deoxythymidylate kinase genetic diversity on HIV-1 hypermutation and response to treatment

  2006cites this paper
• THE INFLUENCE OF APOBEC 3 G AND DEOXYTHYMIDYLATE KINASE GENETIC DIVERSITY ON HIV-1 HYPERMUTATION AND RESPONSE TO TREATMENT

  2006cites this paper
• The effect of long-term storage on measured plasma lactate concentrations and prospective lactate results from a multicenter trial of antiretroviral therapy

  2005cites this paper
• HIV-related neurological disease in the era of HAART.

  2005cites this paper
• HIV neuromuscular disease and mitochondrial function.

  2004cites this paper
• Mitochondrial dysfunction in AIDS and its treatment.

  2004cites this paper
• HIV-associated neuromuscular weakness syndrome

  2004cites this paper
• Peripheral neuropathies in human immunodeficiency virus infection.

  2004cites this paper
• Lactic acidosis in HIV-I infected patients receiving antiretroviral therapy.

  2004cites this paper
• Chapter 22 Peripheral neuropathies in human immunodeficiency virus infection

  2004cites this paper
• HIV neuropathy: time for new therapies

  2004cites this paper
• Experiencia y manejo de las toxicidades en esquemas con inhibidores de transcriptasa reversa análogos de nucleósidos alternativos

  2004cites this paper
• The peripheral nerve complications of human immunodeficiency virus (HIV) infection

  2003cites this paper